*Toxoplasma gondii*, one of the most successful intracellular protozoan parasites, can infect the majority of vertebrate spices including humans with a worldwide distribution \[[@b1-kjp-53-3-345]-[@b3-kjp-53-3-345]\], and approximately one-third of the population has been exposed to *T. gondii*. Normally, the infections are asymptomatic or subclinical. However, the *T. gondii* infection can cause abortion and stillbirth in pregnant women, and encephalitis, chorioretinitis, and systemic infections in immunocompromised individuals \[[@b2-kjp-53-3-345]\]. In animals, *T. gondii* can also cause abortion in livestock, especially in sheep and goats, which can spawn a great number of economic losses in livestock \[[@b3-kjp-53-3-345]\]. However, there was no effective vaccine and drugs that can help to control toxoplasmosis.

The strains of *T. gondii* that predominate in Europe and North America, classified into types I, II, and III, differ in a wide range of phenotypes, including virulence, persistence, migratory capacity, and how they interface with the immune response \[[@b4-kjp-53-3-345]-[@b6-kjp-53-3-345]\], Thus, the information of genetic diversity of *T. gondii* is useful for better understanding epidemiological patterns and pathogenicity, as well as exploring of new polymorphic virulence effectors.

GRA20, a novel dense granule protein, is secreted and targeted to parasitophorous vacuole membrane (PVM), which may participate in the manipulation of the host immunity \[[@b7-kjp-53-3-345]\]. Previous studies have identified the existence of polymorphisms in dense granule proteins, such as GRA15, GRA5, and GRA6 \[[@b8-kjp-53-3-345]-[@b10-kjp-53-3-345]\], but the sequence variation about the *GRA20* gene among different *T. gondii* isolates is still unknown. Therefore, the objective of this study was to examine sequence diversity of *GRA20* gene among *T. gondii* strains from different hosts and geographical regions worldwide.

In this study, a total 16 *T. gondii* strains from different hosts and geographic locations were used for analysis ([Table 1](#t1-kjp-53-3-345){ref-type="table"}). These *T. gondii* isolates have been genotyped and genomic DNA (gDNA) was prepared as described previously \[[@b11-kjp-53-3-345]-[@b13-kjp-53-3-345]\].

To acquire amplicons of *GRA20* genes concerning different *T. gondii* isolates, the primers *GRA20*-F (5´- ATGCATAGCCGGAACTGCGTC-3´) and *GRA20*-R (5´- TCACGCGGGCTTTCTACGG-3´) were designed based on *T. gondii* ME49 strain available in ToxoDB database (TGME49_200010). All the PCR products of GRA20 genes were purified by the DNA purification kit (GenStar, Beijing, China), ligated into pMD18-T vector (TaKaRa, Dalian, China), and then transformed into JM109 competent cells (Promega, Madison, Wisconsin, USA). Subsequently, the positive colonies were screened by PCR, and then sequenced by GenScript Co., Ltd. (Nanjing, China).

The acquired *GRA20* gene sequences were aligned by the Multiple Sequence Alignment Program, Clustal X 1.83 \[[@b14-kjp-53-3-345]\], and sequence variation was determined among the examined *T. gondii* strains. Phylogenetic reconstructions based on the complete sequences of *GRA20* gene among 13 *T. gondii* isolates and plus the corresponding sequences of strains TgCatBr9, VEG, and ME49 available in ToxoDB (<http://toxodb.org/toxo/>) were carried out by 2 inference methods, maximum likelihood (ML) and maximum parsimony (MP) methods by Paup, with the sequence of *Hammondia hammondi* (XM_008890671.1) as the out-group. Phylograms were drawn by the Tree View program version 1.65.

In the present study, the obtained entire genomic sequences of the GRA20 gene were 1,586 bp in length in all examined isolates. According to the analysis of all the 16 GRA20 complete sequences, there were 2 extrons and 1 intron in the *GRA20* gene ([Table 2](#t2-kjp-53-3-345){ref-type="table"}). The A+T content ranged from 45.0% to 45.4% in the entire sequence. There were 124 nucleotide position variations with a distribution of 57 transitions (A↔G and C↔T), 61 transversions (C↔G, T↔G, A↔C, and A↔T) in CDS, and 2 transitions (A↔G and C↔T), and 1 transversion (C↔G, T↔G, A↔C, and A↔T) in the intron ([Table 2](#t2-kjp-53-3-345){ref-type="table"}). However, when we analyzed the *GRA20* sequences without type III (CTG, VEG) strains, there were 12 nucleotide variations with a distribution of 10 transitions (A↔G and C↔T), 2 transversions (C↔G, T↔G, A↔C, and A↔T) in CDS, and 2 transitions (A↔G and C↔T) and 1 transversion (C↔G, T↔G, A↔C, and A↔T) in the intron. The alignment of *GRA20* gene sequences showed that sequence variation was 0-7.9% in all studied strains, while the sequence variation became 0-0.7% without the CTG and VEG strains. Phylogenetic reconstruction of all 16 *T. gondii* strains based on *GRA20* sequence data showed that the type I and type III of *T. gondii* strains were clustered into respective clusters separately ([Fig. 1](#f1-kjp-53-3-345){ref-type="fig"}).

Recently, polymorphisms in the sequences of *GRA5, GRA6, GRA7,* and *GRA15* genes have been reported \[[@b8-kjp-53-3-345],[@b9-kjp-53-3-345],[@b15-kjp-53-3-345],[@b16-kjp-53-3-345]\]. Among them, polymorphic dense granule proteins were widely used in typing *T. gondii* isolates, such as GRA6 \[[@b10-kjp-53-3-345]\]. Furthermore, polymorphic dense granule protein may have different roles in regulating the inflammatory response. For example, GRA15 in type II activate more IL-12 than type I or type III strains \[[@b8-kjp-53-3-345]\]. In this study, we found *GRA20* gene was very diverse in type III, indicating the functions may be different, too. Our results were consistent with that of some previous studies using other genetic markers, such as *GRA5, Rop17*, and *HSP60* for genotyping \[[@b9-kjp-53-3-345],[@b17-kjp-53-3-345],[@b18-kjp-53-3-345]\], but different to some previous studies, such as *Rop38* and *eIF4A* \[[@b19-kjp-53-3-345],[@b20-kjp-53-3-345]\].

In conclusion, the present study examined the sequences of the *T. gondii* *GRA20* gene and revealed that it was more divergence in type III compared to other *T. gondii* strains, suggesting the functions of *GRA20* in type III may be different from other strains. Phylogenetic analysis indicated that the *GRA20* gene could distinguish the type I and type III strains, suggesting the *GRA20* gene may be a novel genetic marker for studying genetic variation or the population genetic structures of *T. gondii* isolates.
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![Phylogram of 16 *Toxoplasma gondii* isolates determined by analysis of the entire sequences of the *GRA20* gene. The tree was reconstructed by maximum parsimony (MP) and maximum likelihood (ML) analyses. The numbers along branches indicate bootstrap values resulting from different analyses in the order: MP/ML.](kjp-53-3-345f1){#f1-kjp-53-3-345}

###### 

Details of *Toxoplasma gondii* isolates used in this research

  Isolate     Host     Geographical location   Genotype^[a](#tfn1-kjp-53-3-345){ref-type="table-fn"}^
  ----------- -------- ----------------------- --------------------------------------------------------
  RH          Human    France                  Reference, type I, ToxoDB \#10
  GT1         Goat     United States           Reference, type I, ToxoDB\#10
  SH          Human    Shanghai, China         type I, ToxoDB \#10
  TgCatBr9    Cat      Brazil                  ToxoDB\#42
  VEG         Human    United States           Reference, ToxoDB\#2
  ME49        Sheep    United States           type II, ToxoDB\#1
  TgCatBr64   Cat      Brazil                  Reference, ToxoDB\#111
  TgCatBr5    Cat      Brazil                  Reference, ToxoDB\#19
  PRU         Human    France                  type II, ToxoDB \#1
  QHO         Sheep    Qinghai, China          type II, ToxoDB \#1
  PTG         Sheep    United States           Reference, type II, ToxoDB\#1
  TgC7        Cat      Guangzhou, China        ToxoDB \#9
  PYS         Pig      Panyu, China            ToxoDB \#9
  CTG         Cat      United States           Reference, type III, ToxoDB\#2
  TgWtdSc40   Deer     USA                     type 12, ToxoDB\#5
  TgToucan    Toucan   Costa Rica              Reference, ToxoDB\#52

Based on the results of Zhou et al. \[[@b11-kjp-53-3-345],[@b12-kjp-53-3-345]\] and Su et al. \[[@b13-kjp-53-3-345]\].

###### 

Characteristics of *Toxoplasma gondii* GRA20 (*TgGRA20*) gene sequences

  Item                                               DNA           CDS^[a](#tfn2-kjp-53-3-345){ref-type="table-fn"}^   First Extron   First Intron   Second Extron                                                           
  -------------------------------------------------- ------------- --------------------------------------------------- -------------- -------------- --------------- ------------- ------------- ------------- ------------- -------------
  Length (bp)                                        1,586         1,586                                               1,242          1,242          140             140           344           344           1,102         1,102
  T+A (%)                                            44.96-45.40   45.02-45.40                                         42.83-43.32    42.91-43.32    45.71-46.43     45.71-46.43   52.62-52.91   52.62-52.91   42.47-42.92   42.56-42.92
  Transition                                         59            12                                                  57             10             1               1             2             2             56            9
  A↔G                                                33            7                                                   31             5              1               1             2             2             30            4
  C↔T                                                26            5                                                   26             5              /               /             /             /             26            5
  Transversion                                       62            3                                                   61             2              0               0             1             1             61            2
  A↔T                                                8             /                                                   8              /              /               /             /             /             8             /
  G↔C                                                17            1                                                   17             1              /               /             /             /             17            1
  A↔C                                                19            2                                                   18             1              /               /             1             1             18            1
  G↔T                                                18            /                                                   18             /              /               /             /             /             18            /
  loss                                               6             0                                                   6              0              0               0             0             0             6             0
  VN^[d](#tfn5-kjp-53-3-345){ref-type="table-fn"}^   127           15                                                  124            12             1               1             3             3             123           11
  R^[e](#tfn6-kjp-53-3-345){ref-type="table-fn"}^    0.95          4                                                   0.93           5              ∖               ∖             2             2             0.92          4.5
  Distance (%)                                       0-7.9         0-0.7                                               0-10.1         0-0.6          0-0.7           0-0.7         0-0.9         0-0.9         0-11.4        0-0.6

CDS: coding sequence.

All: all the *T. gondii* in this study.

Except III: all the *T. gondii* except CTG and VEG.

VN: variable nucleotide.

R=transition/transversion.
